1. Nearly 2.1 million Americans are dependent on prescription opioids according to the National Institute on Drug Abuse.
2. Imprivata has created Confirm ID — a technology that simplifies the two-factor-authentication the U.S. Drug Enforcement Agency requires to electronically write prescriptions for controlled substances.
3. The electronic prescription market is fraught with legislation, but measures are being proposed that would loosen regulations. Imprivata is hoping that its technology will eliminate traditional pen and paper prescription abuse.
4. President of the American Association for the Treatment of Opioid Dependence Mark Parrino is hesitant to say the new technology could eliminate all fraud, and lower the number of opioid abusers. Although he believes it would lessen fraud, he also thinks there would be an uptick in illegal prescription markets.
More stories on how to improve your practice:
1. Rush University Medical Center Orthopedic program 4th in the US, top in Illinois: 3 thoughts
2. 5 things to know about the Access Health Care break-in; patient information may be compromised
3. How one orthopedic group developed physician-owned bundled payments — And scaled their model
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
